Risk-stratified Osteoporosis Strategy Evaluation Study (ROSE)

NCT01388244 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

35000

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis

Interventions

OTHER: Screening
OTHER: Control

Sponsor

Odense University Hospital

Collaborators

[object Object]
[object Object]